What backs a recovery claim?

Ask what is known about the treatment

One peptide sold online has the name BPC-157.

The Food and Drug Administration (FDA) is the agency responsible for medicine reviews in the US.

As of September 2026, FDA did not have enough information from use in people to judge whether BPC-157 could cause harm.

If it is offered for your injury, ask what studies in people support that use and what remains unknown.

Check whether the pharmacy may make it

Compounding means making or mixing a drug for a patient.

TB-500 is the name of another peptide sold online.

Under the federal rules checked as of September 2026, an ordinary pharmacy cannot use BPC-157 or TB-500 as raw ingredients to make a medicine.

If either is offered, ask the pharmacist what current rule allows that exact product. Ask to see the rule itself, rather than a news story.

In its July 2026 review, FDA staff advised keeping BPC-157 off the list of extra ingredients ordinary pharmacies may use to make medicines.

FDA gets advice from a group called the Pharmacy Compounding Advisory Committee.

The staff’s advice does not change the rules, and neither does advice from that committee.

Taking back a request does not allow pharmacy use

The people or groups who asked FDA to allow BPC-157 and TB-500 took back their requests. The page where FDA records those withdrawals is marked current as of April 22, 2026.

That page still lists FDA’s safety concerns about both peptides.

As of September 2026, taking back those requests gave pharmacies no permission to use the ingredients and gave the medicines no FDA approval.

Check the rule behind a meeting headline

As of September 2026, there was no published official FDA record showing how its advisory committee voted at the July 2026 meeting.

A vote from this committee is advice only. Changing the allowed list requires FDA to publish a proposed rule, ask the public for comments, and then issue a final rule.

The July meeting alone did not give pharmacies new permission to use these ingredients.

If an offer relies on a report of that vote, ask for FDA’s written rule that allows the exact ingredient.

Ask what the evidence means for your injury

Ask whether the claim comes from research in people with an injury like yours. Ask what was measured, what care it was compared with, and what is still unknown.

Request the study itself, with a plain explanation of the result. Then ask how that result changes the proposed plan for you.